Tracking the Pharmaceutical Pipeline: Clinical Trials and Global Disease Burden
暂无分享,去创建一个
[1] T. Croghan,et al. The medicine cabinet: what's in it, why, and can we change the contents? , 2004, Health affairs.
[2] E. Dorsey,et al. Financing of U.S. Biomedical Research and New Drug Approvals across Therapeutic Areas , 2009, PloS one.
[3] T. Cymet,et al. The Truth about Drug Companies: How They Deceive Us and What to Do about It , 2006 .
[4] J. Gagne,et al. How many "me-too" drugs is too many? , 2011, JAMA.
[5] Pablo Perel,et al. Relation between the Global Burden of Disease and Randomized Clinical Trials Conducted in Latin America Published in the Five Leading Medical Journals , 2008, PloS one.
[6] J. DiMasi,et al. Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs , 2010, Clinical pharmacology and therapeutics.
[7] John P A Ioannidis,et al. Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research , 2002, BMJ : British Medical Journal.
[8] Johan P Mackenbach,et al. Income inequality and population health , 2002, BMJ : British Medical Journal.
[9] Els Torreele,et al. Drug development for neglected diseases: a deficient market and a public-health policy failure , 2002, The Lancet.
[10] M. Heger. Clinical trial website struggles to serve as research data hub , 2012, Nature Medicine.